1. Home
  2. ABX vs CMPX Comparison

ABX vs CMPX Comparison

Compare ABX & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ABX

Abacus Global Management Inc. Class A Common Stock

N/A

Current Price

$8.35

Market Cap

805.2M

Sector

Finance

ML Signal

N/A

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$5.19

Market Cap

927.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABX
CMPX
Founded
2004
2014
Country
United States
United States
Employees
326
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
805.2M
927.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ABX
CMPX
Price
$8.35
$5.19
Analyst Decision
Hold
Strong Buy
Analyst Count
1
9
Target Price
$11.00
$14.43
AVG Volume (30 Days)
666.6K
1.7M
Earning Date
03-12-2026
03-05-2026
Dividend Yield
2.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.85
N/A
Revenue Next Year
$6.54
$677.91
P/E Ratio
$74.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.18
$1.33
52 Week High
$10.54
$6.88

Technical Indicators

Market Signals
Indicator
ABX
CMPX
Relative Strength Index (RSI) 37.07 41.55
Support Level $7.18 $4.86
Resistance Level $8.78 $5.86
Average True Range (ATR) 0.48 0.29
MACD -0.19 0.01
Stochastic Oscillator 1.59 36.26

Price Performance

Historical Comparison
ABX
CMPX

About ABX Abacus Global Management Inc. Class A Common Stock

Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The company operates through four distinct yet complementary divisions: Abacus Life Solutions, Abacus Asset Group, Abacus Intel, and Abacus Wealth Advisors. It operates through three reportable segments, Asset management, Life solutions, and Technology services. It derives the majority revenue from Life solutions segment that generates revenues by buying, selling, and trading policies, and maintaining policies until receipt of death benefits. It also generates revenue by originating life insurance policy settlements between investors or buyers, and the sellers, who is often the original policy owner.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to target the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-A, Bispecific, and CTX-8371.

Share on Social Networks: